scholarly journals The effect of hyperbaric oxygen therapy on the pathophysiology of skin aging: a prospective clinical trial

Aging ◽  
2021 ◽  
Author(s):  
Yafit Hachmo ◽  
Amir Hadanny ◽  
Sonia Mendelovic ◽  
Pnina Hillman ◽  
Eyal Shapira ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Skin Aging ◽  
Prospective Clinical Trial

scholarly journals Hyperbaric Oxygen Therapy Can Diminish Fibromyalgia Syndrome – Prospective Clinical Trial

PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0127012 ◽  
Author(s):  
Shai Efrati ◽  
Haim Golan ◽  
Yair Bechor ◽  
Yifat Faran ◽  
Shir Daphna-Tekoah ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Fibromyalgia Syndrome ◽  
Oxygen Therapy ◽  
Prospective Clinical Trial

Safety and Tolerability of Hyperbaric Oxygen Therapy in Cats and Dogs

2018 ◽  
Vol 54 (4) ◽  
pp. 188-194 ◽  
Author(s):  
Gemma L. Birnie ◽  
Darren R. Fry ◽  
Matthew P. Best
Keyword(s):  
Clinical Trial ◽  
Adverse Effects ◽  
Clinical Significance ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Air Pressure ◽  
Prospective Clinical Trial ◽  
Treatment Length ◽  
Naturally Occurring

ABSTRACT This prospective clinical trial was designed to evaluate the safety of hyperbaric oxygen therapy (HBOT) in a population of cats and dogs with a variety of naturally occurring diseases. Seventy-eight dogs and twelve cats with various naturally occurring disease conditions, who had the potential to benefit from HBOT, were enrolled in the study. These patients were treated with HBOT in a monoplace hyperbaric oxygen chamber at 2 air pressure absolute for a treatment length of either 45 min or 60 min. There were 230 hyperbaric oxygen treatments performed during the study period. No major adverse effects were observed. There were 76 minor adverse effects recorded, which were not considered to be of clinical significance. Hyperbaric oxygen therapy was well tolerated and there were no major adverse effects recorded during treatment.

scholarly journals Opinions of vascular surgeons and podiatrists in Australia and New Zealand on the use of hyperbaric oxygen therapy for lower limb ulcers

2020 ◽  
Vol 8 (1) ◽  
pp. e001590
Author(s):  
Aaron Drovandi ◽  
Malindu E Fernando ◽  
Tejas P Singh ◽  
Torres Woolley ◽  
Jonathan Golledge
Keyword(s):  
Clinical Trial ◽  
New Zealand ◽  
Hyperbaric Oxygen ◽  
Lower Limb ◽  
Hyperbaric Oxygen Therapy ◽  
Online Survey ◽  
Oxygen Therapy ◽  
Professional Organizations ◽  
Large Clinical Trial ◽  
Venous Ulcers

IntroductionHyperbaric oxygen therapy (HBOT) has been suggested to improve healing of lower limb ulcers, though the quality of available evidence is weak to moderate. This study assessed the opinions and use of HBOT by specialists treating lower limb ulcers.Research design and methodsAccredited vascular surgeons and podiatrists in Australia and New Zealand were sent an online survey via their professional organizations. The survey asked about their use and opinions of HBOT in treating lower limb ischemic, neuropathic and venous ulcers. Data were summarized with descriptive statistics. Non-parametric tests were used to compare survey results obtained from vascular surgeons and podiatrists.Results61 vascular surgeons and 40 podiatrists completed the survey. Thirty-seven specialists used HBOT for treating lower limb ulcers, with the remainder indicating they did not feel there was a role for HBOT (n=25) or did not have access to HBOT (n=39). Less than 8% of specialists indicated that HBOT frequently or always had a role in treating ischemic, neuropathic or venous ulcers. Compared with podiatrists, vascular surgeons were significantly less likely to indicate HBOT had a treatment role for any ulcer type (p<0.001, p=0.004, and p<0.001, respectively), though significantly more likely to indicate they currently used HBOT for treating lower limb ulcers (p<0.001). Most specialists (n=76) believed that a large clinical trial is needed to determine the efficacy of HBOT in treating lower limb ulcers.ConclusionsVascular surgeons and podiatrists do not feel HBOT has a frequent role in treating lower limb ulcers, but do feel there needs to be a large clinical trial to test its value.

scholarly journals Study the effect of hyperbaric oxygen therapy in Egyptian autistic children: A clinical trial

2014 ◽  
Vol 15 (2) ◽  
pp. 155-162 ◽  
Author(s):  
Farida El-baz ◽  
Reham M. Elhossiny ◽  
Yasser Abdel Azeem ◽  
Marianne Girgis
Keyword(s):  
Clinical Trial ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Autistic Children

scholarly journals A single session of hyperbaric oxygen therapy demonstrates acute and long-lasting neuroplasticity effects in humans: a replicated, randomized controlled clinical trial

2019 ◽  
Vol Volume 12 ◽  
pp. 2337-2348
Author(s):  
Anna M Wahl ◽  
Daniel Bidstrup ◽  
Isabel G Smidt-Nielsen ◽  
Mads U Werner ◽  
Ole Hyldegaard ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Single Session ◽  
Randomized Controlled

scholarly journals Refractive change during hyperbaric oxygen therapy. A clinical trial including ultrasound oculometry

2002 ◽  
Vol 80 (2) ◽  
pp. 188-190 ◽  
Author(s):  
Hans C. Fledelius ◽  
Erik C. Jansen ◽  
Jens Thorn
Keyword(s):  
Clinical Trial ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Refractive Change

Effect of hyperbaric oxygen therapy on HMGB1/NF-κB expression and prognosis of acute spinal cord injury: A randomized clinical trial

2019 ◽  
Vol 692 ◽  
pp. 47-52 ◽  
Author(s):  
Lei Sun ◽  
Lin Zhao ◽  
Pinpin Li ◽  
Xuehua Liu ◽  
Fang Liang ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Randomized Clinical Trial ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Acute Spinal Cord Injury ◽  
Cord Injury
Sign in / Sign up

Export Citation Format

Share Document